| Pharmaceutical active ingredients: |
| Bendamustine |
| Available forms, composition and doses of Cytostasan: |
| N / A |
| Cytostasan medical category: |
| Human:Cytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01AA09 - Bendamustine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Cytitone | Cytisine | Unidentified Pharmaceutical Company |
| Cytofol | Folic Acid | Unidentified Pharmaceutical Company |
| Cytokinin | N6-Furfuryladenine | Unidentified Pharmaceutical Company |
| Cytome | Tetracycline | Unidentified Pharmaceutical Company |
| Cytonal | Diethylstilbestrol | Unidentified Pharmaceutical Company |
| Cyuram DS | Tetramethylthiuram | Unidentified Pharmaceutical Company |
| Cyzone | N-Isopropyl-N'-Phenyl-Para-Phenylenediamine | Unidentified Pharmaceutical Company |
| Cyzone IP | N-Isopropyl-N'-Phenyl-Para-Phenylenediamine | Unidentified Pharmaceutical Company |
| Czterochlorek Wegla | Carbon Tetrachloride | Unidentified Pharmaceutical Company |
| D Bretard | Phenformin | Unidentified Pharmaceutical Company |